Skip to content
Disclosery

Nan Fung Group Holdings Ltd

Follow

13F filer, CIK 1782539, KAI TAK, Hong Kong

Nan Fung Group Holdings Ltd reported $131,488,918 across 25 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-13. Its ten largest share positions make up 82.43% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001012975-26-000761

Period
2026-06-30
Reported value
$131M
Holdings
25
Top 10 weight
82.43%
New
2
Sold out
1

Largest buys vs the previous quarter

SecurityShares changeApprox. value
ASNDnew+13,600$3.63M
HELPadded+527,222$3.48M
CHYMnew+21,075$432K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
ASNDexited-13,600-$3.11M
OCSreduced-50,180-$696K
BOLTreduced-24,250-$93.4K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2026

Share positions as resolved from 13F-HR 0001012975-26-000761, largest first. % of portfolio is the value over $131,488,918, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
MPLTMAPLIGHT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 971,253 shares; 2026Q1: 971,253 shares; 2026Q2: 971,253 shares 971,253$34.8M26.47%0Timeline
LBRXLB PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 300,000 shares; 2025Q4: 300,000 shares; 2026Q1: 630,657 shares; 2026Q2: 630,657 shares 630,657$20.5M15.57%0Timeline
EVMNEVOMMUNE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,441,032 shares; 2026Q1: 1,441,032 shares; 2026Q2: 1,441,032 shares 1,441,032$19.2M14.56%0Timeline
HELPCYBIN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 460,000 shares; 2026Q1: 460,000 shares; 2026Q2: 987,222 shares 987,222$6.53M4.96%+527,222Timeline
INCYINCYTE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 74,022 shares; 2024Q4: 67,022 shares; 2025Q1: 59,022 shares; 2025Q2: 59,022 shares; 2025Q3: 59,022 shares; 2025Q4: 59,022 shares; 2026Q1: 53,742 shares; 2026Q2: 53,742 shares 53,742$6.09M4.63%0Timeline
RYTMRHYTHM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 49,120 shares; 2024Q4: 49,120 shares; 2025Q1: 49,120 shares; 2025Q2: 49,120 shares; 2025Q3: 49,120 shares; 2025Q4: 49,120 shares; 2026Q1: 49,120 shares; 2026Q2: 49,120 shares 49,120$5.45M4.15%0Timeline
ONCBEONE MEDICINES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 23,022 shares; 2024Q4: 19,997 shares; 2025Q1: 15,722 shares; 2025Q2: 15,722 shares; 2025Q3: 15,722 shares; 2025Q4: 15,722 shares; 2026Q1: 15,722 shares; 2026Q2: 15,722 shares 15,722$4.48M3.41%0Timeline
OCSOCULIS HOLDING AGQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 436,378 shares; 2024Q4: 436,378 shares; 2025Q1: 514,702 shares; 2025Q2: 514,702 shares; 2025Q3: 514,702 shares; 2025Q4: 514,702 shares; 2026Q1: 350,745 shares; 2026Q2: 300,565 shares 300,565$4.17M3.17%-50,180Timeline
ASNDASCENDIS PHARMA A/SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 13,600 shares 13,600$3.63M2.76%newTimeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 7,300 shares; 2024Q4: 19,253 shares; 2025Q1: 19,253 shares; 2025Q2: 19,253 shares; 2025Q3: 19,253 shares; 2025Q4: 19,253 shares; 2026Q1: 19,253 shares; 2026Q2: 19,253 shares 19,253$3.61M2.74%0Timeline
KYMRKYMERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 10,875 shares; 2024Q4: 30,875 shares; 2025Q1: 30,875 shares; 2025Q2: 30,875 shares; 2025Q3: 30,875 shares; 2025Q4: 30,875 shares; 2026Q1: 30,875 shares; 2026Q2: 30,875 shares 30,875$3.54M2.69%0Timeline
MDGLMADRIGAL PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 9,762 shares; 2024Q4: 11,122 shares; 2025Q1: 11,872 shares; 2025Q2: 11,872 shares; 2025Q3: 11,872 shares; 2025Q4: 11,872 shares; 2026Q1: 5,672 shares; 2026Q2: 5,672 shares 5,672$3.05M2.32%0Timeline
CELCCELCUITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 28,300 shares; 2026Q2: 28,300 shares 28,300$2.96M2.25%0Timeline
ACADACADIA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 102,984 shares; 2024Q4: 102,984 shares; 2025Q1: 102,984 shares; 2025Q2: 102,984 shares; 2025Q3: 102,984 shares; 2025Q4: 102,984 shares; 2026Q1: 102,984 shares; 2026Q2: 102,984 shares 102,984$2.61M1.98%0Timeline
ARGXARGENX SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 430 shares; 2024Q4: 430 shares; 2025Q1: 2,800 shares; 2025Q2: 2,800 shares; 2025Q3: 2,800 shares; 2025Q4: 2,800 shares; 2026Q1: 2,800 shares; 2026Q2: 2,800 shares 2,800$2.6M1.98%0Timeline
RXRXRECURSION PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 664,610 shares; 2025Q1: 664,610 shares; 2025Q2: 664,610 shares; 2025Q3: 595,287 shares; 2025Q4: 595,287 shares; 2026Q1: 595,287 shares; 2026Q2: 595,287 shares 595,287$2.18M1.66%0Timeline
PCORPROCORE TECHNOLOGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 53,299 shares; 2026Q1: 53,299 shares; 2026Q2: 53,299 shares 53,299$2.17M1.65%0Timeline
HRMYHARMONY BIOSCIENCES HLDGS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 368,665 shares; 2024Q4: 368,665 shares; 2025Q1: 368,665 shares; 2025Q2: 368,665 shares; 2025Q3: 27,049 shares; 2025Q4: 27,049 shares; 2026Q1: 27,049 shares; 2026Q2: 27,049 shares 27,049$985K0.75%0Timeline
INSMINSMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 6,580 shares; 2026Q2: 6,580 shares 6,580$702K0.53%0Timeline
ETHAISHARES ETHEREUM TRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 50,549 shares; 2025Q4: 50,549 shares; 2026Q1: 50,549 shares; 2026Q2: 50,549 shares 50,549$601K0.46%0Timeline
IBITISHARES BITCOIN TRUST ETFQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 15,968 shares; 2025Q4: 15,968 shares; 2026Q1: 15,968 shares; 2026Q2: 15,968 shares 15,968$532K0.4%0Timeline
CHYMCHIME FINL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 21,075 shares 21,075$432K0.33%newTimeline
RANIRANI THERAPEUTICS HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 493,584 shares; 2024Q4: 493,584 shares; 2025Q1: 493,584 shares; 2025Q2: 493,584 shares; 2025Q3: 493,584 shares; 2025Q4: 493,584 shares; 2026Q1: 493,584 shares; 2026Q2: 493,584 shares 493,584$375K0.29%0Timeline
TRDAENTRADA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 49,082 shares; 2024Q4: 49,082 shares; 2025Q1: 49,082 shares; 2025Q2: 49,082 shares; 2025Q3: 49,082 shares; 2025Q4: 49,082 shares; 2026Q1: 49,082 shares; 2026Q2: 49,082 shares 49,082$361K0.27%0Timeline
BOLTBOLT BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 58,347 shares; 2025Q3: 58,347 shares; 2025Q4: 58,347 shares; 2026Q1: 29,250 shares; 2026Q2: 5,000 shares 5,000$19.2K0.01%-24,250Timeline

Sold out in Q2 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
ASNDASCENDIS PHARMA A/S13,600$3.11Mshares

How Q2 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001012975-26-000761 base2026-08-13acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0001012975-26-000761 Quarter ended 2026-06-302026-08-13acceptance time not in the bulk data set
13F-HR 0001012975-26-000423 Quarter ended 2026-03-312026-05-14acceptance time not in the bulk data set
13F-HR 0001012975-26-000144 Quarter ended 2025-12-312026-02-13acceptance time not in the bulk data set
13F-HR 0001012975-25-000750 Quarter ended 2025-09-302025-11-13acceptance time not in the bulk data set
13F-HR 0001012975-25-000440 Quarter ended 2025-06-302025-08-13acceptance time not in the bulk data set
13F-HR 0001012975-25-000235 Quarter ended 2025-03-312025-05-14acceptance time not in the bulk data set
13F-HR 0001012975-25-000083 Quarter ended 2024-12-312025-02-13acceptance time not in the bulk data set
13F-HR 0001012975-24-000473 Quarter ended 2024-09-302024-11-13acceptance time not in the bulk data set
13F-HR 0001012975-24-000323 Quarter ended 2024-06-302024-08-13acceptance time not in the bulk data set
13F-HR 0001012975-24-000206 Quarter ended 2024-03-312024-05-14acceptance time not in the bulk data set
13F-HR 0001012975-24-000077 Quarter ended 2023-12-312024-02-13acceptance time not in the bulk data set
13F-HR 0001012975-23-000456 Quarter ended 2023-09-302023-11-13acceptance time not in the bulk data set
13F-HR 0001012975-23-000332 Quarter ended 2023-06-302023-08-11acceptance time not in the bulk data set
13F-HR 0001012975-23-000216 Quarter ended 2023-03-312023-05-12acceptance time not in the bulk data set
13F-HR 0001012975-23-000084 Quarter ended 2022-12-312023-02-13acceptance time not in the bulk data set
13F-HR 0001012975-22-000486 Quarter ended 2022-09-302022-11-10acceptance time not in the bulk data set
13F-HR 0001012975-22-000350 Quarter ended 2022-06-302022-08-12acceptance time not in the bulk data set
13F-HR 0001012975-22-000224 Quarter ended 2022-03-312022-05-13acceptance time not in the bulk data set
13F-HR 0001012975-22-000078 Quarter ended 2021-12-312022-02-14acceptance time not in the bulk data set
13F-HR 0001012975-21-000454 Quarter ended 2021-09-302021-11-15acceptance time not in the bulk data set
13F-HR 0001012975-21-000351 Quarter ended 2021-06-302021-09-22acceptance time not in the bulk data set